Switch to:

Beam Therapeutics Interest Expense

: $-0.19 Mil (TTM As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Beam Therapeutics's interest expense for the three months ended in Mar. 2020 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2020 was $-0.19 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Beam Therapeutics's Operating Income for the three months ended in Mar. 2020 was $ -28.36 Mil. Beam Therapeutics's Interest Expense for the three months ended in Mar. 2020 was $ 0.00 Mil. GuruFocus does not calculate Beam Therapeutics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Beam Therapeutics Interest Expense Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Interest Expense 0.00 0.00 -0.19

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Interest Expense Premium Member Only Premium Member Only 0.00 0.00 -0.07 -0.12 0.00

Beam Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2020 was 0 (Jun. 2019 ) + -0.068 (Sep. 2019 ) + -0.119 (Dec. 2019 ) + 0 (Mar. 2020 ) = $-0.19 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics  (NAS:BEAM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beam Therapeutics's Interest Expense for the three months ended in Mar. 2020 was $0.00 Mil. Its Operating Income for the three months ended in Mar. 2020 was $-28.36 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2020 was $29.39 Mil.

Beam Therapeutics's Interest Coverage for the quarter that ended in Mar. 2020 is calculated as

GuruFocus does not calculate Beam Therapeutics's interest coverage with the available data.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

The higher the ratio, the stronger the company's financial strength is.


Beam Therapeutics Interest Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)